Ethnopharmacological Studies of Aloe Vera for the Management of Eczema Followed by Molecular Techniques through Metabolomics & Novel Drug Delivery System

Author Details

Hari Baskar, Umama Yezdani, Mohammad Gayoor kha, RidhimaBatra, Gulafsha fatima, Karthikeyan lakshmanan, Raja Muthusamy

Journal Details

Published

Published: 17 January 2020 | Article Type :

Abstract

Eczema is skin very serious skin disease of skin inflammation that causes the skin to become itchy, red, swollen and painful. It is also called as Atopic dermatitis usually developed on early stage of children in India 10 million cases per year is observed. Atopic dermatitis is also passed one general to next generation & the treatment is self diagnosable lab test or Imaging not required. Eczema developed with allergies such as asthma, cold sores etc. It usually starts on the face followed by the hands and feet. Older children tend to be affected in the elbow and knee creases, neck, wrists, ankles and feet. Genetic mutations that affect the skin's barrier function Immune system dysfunction causing an unwanted inflammatory response in the skin. Certain substances or conditions called trigger factors can cause eczema to flare (ie: become worse). Trigger including such as Irritants such as soaps and detergents, wool, skin infections, dry skin, low humidity, heat, sweating or emotional stress. Allergens such as food is also included.

Keywords: Atopic dermatitis , Genetic Mutation, allergies, infection, Immune system dysfunction

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © Author(s) retain the copyright of this article.

Statistics

124 Views

333 Downloads

Volume & Issue

Article Type

How to Cite

Citation:

Hari Baskar, Umama Yezdani, Mohammad Gayoor kha, RidhimaBatra, Gulafsha fatima, Karthikeyan lakshmanan, Raja Muthusamy. (2020-01-17). "Ethnopharmacological Studies of Aloe Vera for the Management of Eczema Followed by Molecular Techniques through Metabolomics & Novel Drug Delivery System." *Volume 4*, 1, 1-5